A new manuscript from the IGNITE Pragmatic Trials Network has been published in JAMA Network Open, describing the primary results of the GUARDD-US study. GUARDD-US is a randomized controlled trial examining the impact of returning APOL1 genetic risk results to ...
Keystone Symposia Precision Genome Engineering March 9 – 12 | Banff, Alberta, Canada This Keystone Symposia conference will bring together leaders in genome editing to explore fundamental biology, technology advances, […]
American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting March 10 – 14 | Baltimore, MD Hosted by the American College of Medical Genetics and Genomics, this meeting […]
GMKB